Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HypoDeg: Insulin Degludec vs Glargine in High-Risk T1D
NCT02192450Phase 4Completed
- Sponsor
- Nordsjællands Hospital
- Start
- Jan 2015
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin degludec in type 1 diabetes mellitus (T1D), sponsored by Nordsjællands Hospital. Started Jan 2015; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02192450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192450.